跳至主要内容
临床试验/NCT01975168
NCT01975168Unknown不适用

The Effect Evaluation of Laser Acupuncture in Obesity

Kaohsiung Medical University Chung-Ho Memorial Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2013年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
body composition

研究概览

简要总结

A randomized double-blind placebo-controlled crossover trial is conducted. 200 subjects aged above 20 years with body mass index (BMI) more than 25 kg/m2 are randomly divided into 2 groups (Group 1 and Group 2). Group 1 receives laser acupuncture therapy first while Group 2 receives sham laser acupuncture therapy first. After 12 weeks of treatment and 14 days of washout, Group 1 switch to sham laser acupuncture therapy while Group 2 switch to laser acupuncture for 12 weeks. The subjects are treated with a gallium aluminum arsenide Handylaser Trion, which is used to apply at each of the acupuncture points for 10 seconds every time, 3 times per week. The measurements of outcomes are performed in the beginning, weekly during treatment, and monthly after treatment for 3 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Body Mass Index over 25 kg/m2 or Waist girth over 80cm in female, waist girth over 90cm in male

排除标准

  • •Pathmakers user
  • •Epilepsy history
  • •Pregnancy
  • •Immuno-inhibiting agents user
  • •Malignancy
  • •Skin contacted disease
  • •Weight controlled agents user during trial period
  • •Eating disorder

研究组 & 干预措施

Group 1

Experimental

arrange laser acupuncture intervention for 12 weeks, then cross over to sham laser acupuncture intervention for 12 weeks

干预措施: Handylaser Trion laser acupuncture (Device)

Group 2

Sham Comparator

arrange sham laser acupuncture for 12 weeks, then cross over to laser acupuncture for 12 weeks

干预措施: Handylaser Trion laser acupuncture (Device)

结局指标

主要结局

body composition

时间窗: 12 weeks

body weight

次要结局

  • body mass index(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cheng-Che Lin

Doctor of Chinese Medicine Department

Kaohsiung Medical University Chung-Ho Memorial Hospital

研究点 (1)

Loading locations...

相似试验